ArticleThe international journal of neuropsychopharmacology2022

5-HT5A Receptor Antagonist ASP5736 Ameliorates Several Abnormal Behaviors in an Fmr1-Targeted Transgenic Male Rat Model of Fragile X Syndrome.

Mayako Yamazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.